

Recurrent pregnancy loss causes real, lasting grief. If you keep having miscarriages, you deserve more than vague reassurance. You deserve answers. Recurrent pregnancy loss (RPL) means losing two or more pregnancies before 20 weeks. It affects roughly 1 to 5 percent of couples trying to conceive, according to ACOG. While one miscarriage is often random, two or more miscarriages signal that something needs investigation. This article breaks down every known cause, every recommended test, and every evidence-based treatment option available today. By the end, you will understand what is happening in your body and what your next step should be.
The American Society for Reproductive Medicine (ASRM) defines recurrent pregnancy loss as two or more clinically recognized pregnancy losses. The European Society for Human Reproduction and Embryology (ESHRE) uses the same threshold. Only about 2 percent of women experience two consecutive losses. About 1 percent face three or more. These numbers confirm that RPL is not simply bad luck repeated twice.
A clinical pregnancy is one confirmed by ultrasound or tissue examination. Biochemical pregnancies, where only a hormone test briefly turns positive, now count toward the RPL definition in most modern guidelines. This matters because many women experience biochemical losses without realizing they were pregnant at all.
In addition, up to 50 percent of RPL cases have no obvious cause even after full testing, according to UCSF Health. This frustrates both patients and their doctors. However, not finding a cause does not mean that future pregnancies will fail. Most women with unexplained RPL still go on to have a healthy baby.
The body loses a pregnancy for many reasons. Some causes repeat every time. Others are purely random. The distinction matters because only recurring causes respond to targeted treatment.
Think of it this way. If 60 percent of first-trimester losses happen because of random chromosomal errors, many miscarriages will never repeat. The embryo had a one-time abnormality. Nothing caused it. Nothing will cause it again. However, some causes consistently harm the uterine environment or the embryo at every attempt. These are the causes this article focuses on.
Researchers at Washington University in St. Louis note that even after two miscarriages with no treatment, 65 percent of women achieve a successful next pregnancy. However, that figure drops as losses accumulate and as age increases. Finding and addressing a cause shortens the journey to a healthy baby.
Chromosomal problems cause the largest share of pregnancy losses overall. According to ACOG, roughly 50 percent of all early pregnancy losses involve fetal chromosomal abnormalities. In RPL specifically, abnormal chromosomes explain around 50 to 80 percent of first-trimester losses.
Two chromosomal mechanisms drive RPL. First, random aneuploidy occurs when an embryo receives too many or too few chromosomes during fertilization. This happens by chance and rarely repeats. Second, structural chromosomal rearrangements in one or both parents pass consistently to embryos. Balanced translocations cause 2 to 5 percent of RPL cases in couples.
A balanced translocation means a piece of one chromosome has relocated to another. The parent with the translocation is healthy because they have the right total amount of genetic material. However, some of their eggs or sperm carry an unbalanced form. Those embryos cannot survive. Parental karyotyping catches this problem. According to ASRM guidelines, genetic counseling is the recommended first step when parental karyotype abnormalities appear.
Structural problems of the uterus account for about 15 percent of RPL cases, according to Washington University Fertility Center. Some uterine problems develop before birth. Others develop after injury, surgery, or infection.
A septate uterus is the most common structural abnormality linked to RPL. A tissue wall divides the uterine cavity partially or completely. Embryos that implant on the septum receive poor blood supply and often fail. Hysteroscopic resection of the septum restores near-normal pregnancy outcomes, with term delivery rates reaching 75 percent and live birth rates approaching 85 percent in many studies.
Other structural issues include fibroids, intrauterine adhesions (Asherman syndrome), and bicornuate or unicornuate uterus. Submucosal fibroids of any size and intramural fibroids larger than 5 cm consistently disrupt implantation. Treating surgically accessible fibroids and polyps reduces the miscarriage rate in women with RPL.
Antiphospholipid syndrome (APS) is the most important and treatable immune cause of recurrent pregnancy loss. A PMC review describes APS as the single most curable reason for RPL. Between 5 and 20 percent of women with RPL test positive for antiphospholipid antibodies.
In APS, the immune system produces antibodies that attack phospholipid-binding proteins. These antibodies interfere with placental development and blood flow. Clots form in placental blood vessels. The pregnancy fails. APS causes losses throughout the pregnancy, not just early on.
The ACOG guideline on early pregnancy loss states that only APS has shown a consistent, significant link to recurrent early pregnancy loss among immune conditions. Treatment with low-dose aspirin and heparin is both evidence-based and highly effective. Women with APS and RPL who receive this combination treatment achieve live birth rates between 70 and 80 percent.
Hormonal problems account for 8 to 12 percent of RPL cases, according to Frontiers in Endocrinology. The endocrine system must work correctly for a pregnancy to implant and grow.
Thyroid dysfunction is among the most common hormonal causes. Both hypothyroidism and elevated thyroid peroxidase antibodies raise miscarriage risk. Women with thyroid antibodies who receive levothyroxine may reduce their miscarriage rate, though evidence remains mixed in euthyroid women.
Polycystic ovary syndrome (PCOS) also increases miscarriage risk. Insulin resistance, high androgen levels, and abnormal endometrial development all contribute. Treating the underlying metabolic imbalance improves outcomes in women with PCOS and RPL.
Luteal phase deficiency and uncontrolled diabetes mellitus round out the major hormonal causes. Progesterone plays a critical role in maintaining early pregnancy. Women who bleed in the first trimester and have a history of miscarriage benefit from progesterone supplementation according to current Canadian, ESHRE, and RCOG guidelines.
Thrombophilias are conditions that make blood clot too easily. Inherited thrombophilias include Factor V Leiden mutation and prothrombin gene mutations. These conditions reduce blood flow through placental vessels, starving the growing pregnancy.
However, the link between inherited thrombophilias and RPL is less clear than with APS. The ACOG guideline states that anticoagulants and aspirin do not reduce miscarriage risk in women with inherited thrombophilias unless APS is also present. Therefore, testing for inherited thrombophilias is not universally recommended for RPL outside of specific clinical scenarios.
Autoimmune factors explain roughly 20 percent of RPL cases, according to a 2024 ScienceDirect review. These include abnormal immune cell activity, altered cytokine production, and other immune imbalances.
Natural killer (NK) cells play a complex role at the uterine lining. In normal pregnancy, NK cells help build blood vessels in the endometrium. In some women with RPL, NK cell activity is dysregulated. However, routine NK cell testing is not currently recommended because standard testing does not reliably predict pregnancy outcomes.
Chronic endometritis is another emerging immune cause. Bacterial infection of the uterine lining triggers an inflammatory response that disrupts implantation. Treating confirmed chronic endometritis with targeted antibiotics reduces the subsequent miscarriage rate in some studies.
For many years, doctors viewed RPL as a female problem alone. Research has changed this view entirely. A 2014 study highlighted in a PMC review found that sperm from men whose partners experienced RPL had significantly reduced viability, lower progressive motility, and higher rates of abnormal morphology. High sperm DNA fragmentation is now considered a contributing cause in some RPL couples.
Sperm quality testing should form part of an RPL workup when standard female investigation returns normal results. Lifestyle changes, antioxidant supplements, and treating underlying infections can improve sperm DNA fragmentation.
Several modifiable lifestyle factors consistently raise miscarriage risk. Smoking, excess alcohol, high caffeine intake, and obesity all contribute. Increasing body mass index correlates directly with a higher risk of pregnancy loss.
The Canadian SOGC guideline on RPL supports lifestyle modification as a core component of RPL management. Reducing caffeine intake below 200 mg per day, stopping smoking, and achieving a healthy weight before conception all improve live birth rates. Evidence also supports a Mediterranean-style diet for women with RPL.
A thorough recurrent miscarriage workup identifies a treatable cause in roughly 50 percent of couples. The ASRM recommends starting evaluation after two consecutive clinical losses.
The core RPL workup includes the following tests and investigations:
Parental karyotyping: Blood tests check both partners for chromosomal rearrangements. A result showing a balanced translocation leads to genetic counseling and possible preimplantation genetic testing (PGT).
Antiphospholipid antibody testing: This tests for lupus anticoagulant, anticardiolipin antibodies (IgG and IgM), and anti-beta-2 glycoprotein I antibodies. Positive results must be confirmed on a second test at least 12 weeks later.
Uterine assessment: Pelvic ultrasound, saline infusion sonohysterography (SIS), hysterosalpingography (HSG), or hysteroscopy all evaluate the uterine cavity. Each has slightly different strengths. Your doctor selects the best option based on your clinical picture.
Thyroid function and antibody testing: TSH levels and thyroid peroxidase antibody levels identify treatable thyroid problems. Thyroid disorders are among the most correctable causes of RPL.
Blood glucose and metabolic screening: Testing for insulin resistance, PCOS, and diabetes reveals endocrine contributions to RPL.
Products of conception (POC) testing: When a miscarriage occurs, chromosomal analysis of the pregnancy tissue can determine whether the loss was chromosomally abnormal. This guides future treatment decisions.
Sperm DNA fragmentation testing: Where standard investigations return normal, evaluating sperm DNA integrity adds another layer of diagnostic clarity.
Tests that current guidelines do not recommend as routine include NK cell testing, full thrombophilia panels, and immunological biomarkers beyond APS antibodies. According to the SOGC Guideline No. 464, immune testing should not form a routine part of the RPL workup.
Unexplained recurrent pregnancy loss is the diagnosis given when a full workup finds no cause. This happens in 50 to 75 percent of RPL cases, according to Washington University Fertility Center.
An unexplained diagnosis feels deflating. However, it carries a surprisingly good prognosis. Women with unexplained RPL who receive supportive care in a dedicated early pregnancy unit achieve subsequent live birth rates of up to 75 percent without additional medication.
A landmark study cited in a PMC review on RPL etiology found that supportive antenatal care alone produced an 86 percent pregnancy success rate compared to 33 percent in women who received no extra attention. This striking difference shows the profound impact of emotional support and close monitoring on pregnancy outcomes in unexplained RPL.
For unexplained RPL with first-trimester vaginal bleeding, progesterone supplementation is recommended by current guidelines. Some trials show benefit, particularly when treatment begins in the luteal phase before a positive pregnancy test. Discuss this option with your doctor before your next attempt.
Treatment targets the underlying cause whenever possible. The ASRM committee opinion maps treatment directly to etiology. No single treatment works for all types of RPL.
For APS: Low-dose aspirin started before conception plus prophylactic heparin once pregnancy is confirmed. This combination raises live birth rates to 70 to 80 percent in women with confirmed APS and RPL.
For uterine septum: Hysteroscopic resection is the treatment of choice. Term delivery rates reach approximately 75 percent after successful resection.
For thyroid disorders: Levothyroxine normalizes thyroid function. Women with thyroid antibodies who start treatment before conception may see improved outcomes.
For chromosomal translocations: Preimplantation genetic testing (PGT) through IVF identifies chromosomally normal embryos before transfer. This reduces miscarriage rate and may shorten the time to the first live birth.
For PCOS: Treating insulin resistance, achieving a healthy weight, and managing androgen levels improve pregnancy outcomes. Metformin does not have sufficient evidence to recommend routinely for RPL prevention.
For unexplained RPL: Supportive care, emotional support, close monitoring, and progesterone supplementation in the first trimester for women who bleed. Aspirin and heparin without confirmed APS do not improve outcomes.
For lifestyle factors: Stopping smoking, cutting caffeine, limiting alcohol, and reaching a healthy weight before conception reduce miscarriage risk for all women with RPL.
The medical facts of RPL tell only part of the story. A comprehensive PMC review documents the grief, guilt, fear, relationship strain, and depression that RPL causes in both partners. Women with RPL are at higher risk for clinical depression and anxiety. The problem cuts especially deep in cultures where a woman’s role centers on motherhood and family.
Partners suffer too. Men with RPL partners often feel helpless and excluded from the grief process. Relationship conflict and loss of intimacy are documented consequences of repeated pregnancy loss.
The ACOG repeated miscarriages resource recommends seeking counseling and joining support groups after RPL. Psychological care is not a luxury in RPL management. It is an essential part of treatment. Research shows that emotional distress does not worsen the chance of a future live birth. Seeking help for your mental health does not harm your chances of conceiving.
How many miscarriages qualify as recurrent pregnancy loss?
Two or more clinically confirmed pregnancy losses qualify as recurrent pregnancy loss under ASRM and ESHRE guidelines. Some older definitions required three losses. Current evidence supports starting an evaluation after two losses, especially in women over 35 or those who have never had a live birth.
What is the most common cause of recurrent pregnancy loss?
Chromosomal abnormalities cause the largest proportion of individual miscarriages. Among recurring structural causes, antiphospholipid syndrome and uterine anomalies are the most commonly identified and treatable causes in women with RPL.
Can antiphospholipid syndrome be treated during pregnancy?
Yes. Women with confirmed APS and RPL receive low-dose aspirin started before conception and heparin once pregnancy is confirmed. This combination restores live birth rates to 70 to 80 percent in women who have the condition, according to ACOG and ASRM guidelines.
Does unexplained recurrent pregnancy loss mean I will never carry to term?
No. About 65 percent of women with unexplained RPL achieve a successful next pregnancy without targeted treatment. With supportive care, emotional support, and close monitoring in a dedicated early pregnancy unit, that figure can rise even higher.
Can a man cause recurrent miscarriage?
Yes. High sperm DNA fragmentation and poor sperm quality contribute to RPL in some couples. Research shows that sperm from men in RPL couples has lower viability and higher DNA damage than sperm from men in control groups. Sperm testing is worth requesting if female investigations return normal.
What tests should a doctor run for recurrent pregnancy loss?
A complete RPL workup should include parental karyotyping, antiphospholipid antibody testing (lupus anticoagulant, anticardiolipin, anti-beta-2 glycoprotein I), uterine cavity imaging, thyroid function tests, and blood glucose screening. Products of conception testing after each loss adds valuable information. Sperm DNA fragmentation testing is appropriate when standard female investigations are normal.
Does stress cause recurrent miscarriage?
Stress does not directly cause recurrent pregnancy loss. A longitudinal cohort study found that self-reported emotional distress did not predict future miscarriage. However, stress management and psychological support improve quality of life and may improve the pregnancy environment indirectly.
Can PCOS cause recurrent pregnancy loss?
Yes. PCOS raises miscarriage risk through insulin resistance, elevated androgens, and endometrial dysfunction. Treating the underlying metabolic factors through weight management, diet, and medication improves outcomes. However, metformin alone does not have strong enough evidence to recommend routinely for RPL prevention.
Is IVF with PGT the best treatment for recurrent pregnancy loss?
Not for everyone. IVF with preimplantation genetic testing is most beneficial for couples where one partner carries a chromosomal rearrangement. For other causes, targeted treatment without IVF is often equally effective and significantly less expensive. Discuss the right approach with a reproductive endocrinologist.
What lifestyle changes reduce the risk of another miscarriage?
Stop smoking. Reduce caffeine to below 200 mg daily. Avoid alcohol. Reach a healthy body weight before conception. Eat a Mediterranean-style diet. These changes reduce miscarriage risk for all women with RPL, regardless of the underlying cause.
How long should I wait before trying again after a miscarriage?
You can ovulate as early as two weeks after an early miscarriage. ACOG recommends discussing timing with your doctor based on your individual circumstances. Emotional readiness matters as much as physical recovery.
What is the live birth rate after recurrent pregnancy loss?
Even after three miscarriages, most women eventually achieve a live birth. Women under 30 with RPL have approximately a 75 percent chance of live birth within two years. Women over 40 with RPL have about a 40 percent chance. Finding and treating a specific cause improves these figures significantly.
Recurrent pregnancy loss causes are real, identifiable, and in many cases treatable. Start with a visit to a reproductive endocrinologist or a specialist in recurrent miscarriage. Ask for a full workup that includes chromosomal testing, APS antibody panels, uterine imaging, and thyroid assessment. Bring your partner. Both of you are part of this investigation and both of you deserve answers.
If your tests return normal, do not lose hope. Supportive care and early pregnancy monitoring significantly improve outcomes even in unexplained cases. The evidence is clear that most women with RPL eventually carry a pregnancy to term.
Seek emotional support alongside medical care. Talk to a counselor. Connect with support communities that understand your experience. You are not alone in this. Recurrent pregnancy loss is one of reproductive medicine’s most complex challenges. But specialists continue to make progress, and outcomes continue to improve. The next pregnancy can be different.
Get expert, compassionate care for your women’s and reproductive health. Dr. Muibat Adeniran, a certified Obstetrician & Gynaecologist, provides personalized and confidential consultations.
Support for:
• Menstrual health
• Family planning & counseling
• Infertility concerns
• Sexual health
• STI consultation
• Test review & guidance
✅ Take the first step toward better health.